Cargando…
Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
In addition to the rapid development of immune checkpoint inhibitors, there has also been a surge in the development of self-assembly immunotherapy drugs. Based on the immune target, traditional tumor immunotherapy drugs are classified into five categories, namely immune checkpoint inhibitors, direc...
Autores principales: | Zhang, Wei, Zheng, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110942/ https://www.ncbi.nlm.nih.gov/pubmed/37081982 http://dx.doi.org/10.3389/fonc.2023.1122322 |
Ejemplares similares
-
Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022) -
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018) -
Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022) -
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)